Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Intravenous Delivery of miR-21 Inhibitor in Mice With Head and Neck Squamous Cell Carcinoma

HAJIME ISHINAGA, TARO YASUMA, CORINA N. D’ALESSANDRO-GABAZZA, VALERIA FRIDMAN D’ALESSANDRO, MASAAKI TODA, ESTEBAN C. GABAZZA and KAZUHIKO TAKEUCHI
Anticancer Research August 2023, 43 (8) 3487-3491; DOI: https://doi.org/10.21873/anticanres.16525
HAJIME ISHINAGA
1Department of Otorhinolaryngology-Head & Neck Surgery, Mie University Graduate School of Medicine, Mie, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: hajime{at}med.mie-u.ac.jp
TARO YASUMA
2Department of Immunology, Mie University Graduate School of Medicine, Mie, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CORINA N. D’ALESSANDRO-GABAZZA
2Department of Immunology, Mie University Graduate School of Medicine, Mie, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
VALERIA FRIDMAN D’ALESSANDRO
2Department of Immunology, Mie University Graduate School of Medicine, Mie, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MASAAKI TODA
2Department of Immunology, Mie University Graduate School of Medicine, Mie, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ESTEBAN C. GABAZZA
2Department of Immunology, Mie University Graduate School of Medicine, Mie, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KAZUHIKO TAKEUCHI
1Department of Otorhinolaryngology-Head & Neck Surgery, Mie University Graduate School of Medicine, Mie, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.

patientACCESS

patientACCESS - Patients desiring access to articles
PreviousNext
Back to top

In this issue

Anticancer Research: 43 (8)
Anticancer Research
Vol. 43, Issue 8
August 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Intravenous Delivery of miR-21 Inhibitor in Mice With Head and Neck Squamous Cell Carcinoma
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
6 + 6 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Intravenous Delivery of miR-21 Inhibitor in Mice With Head and Neck Squamous Cell Carcinoma
HAJIME ISHINAGA, TARO YASUMA, CORINA N. D’ALESSANDRO-GABAZZA, VALERIA FRIDMAN D’ALESSANDRO, MASAAKI TODA, ESTEBAN C. GABAZZA, KAZUHIKO TAKEUCHI
Anticancer Research Aug 2023, 43 (8) 3487-3491; DOI: 10.21873/anticanres.16525

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Intravenous Delivery of miR-21 Inhibitor in Mice With Head and Neck Squamous Cell Carcinoma
HAJIME ISHINAGA, TARO YASUMA, CORINA N. D’ALESSANDRO-GABAZZA, VALERIA FRIDMAN D’ALESSANDRO, MASAAKI TODA, ESTEBAN C. GABAZZA, KAZUHIKO TAKEUCHI
Anticancer Research Aug 2023, 43 (8) 3487-3491; DOI: 10.21873/anticanres.16525
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Conclusion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Isolation and Characterization of Putative Cancer Stem Cells from Oral Squamous Cell Carcinoma Cells
  • Focused Ultrasound-mediated Disruption of Plasma Protein Binding Enhances Chemotherapeutic Effects of Paclitaxel on Xenografted Ovarian Cancer in Mice
  • MGMT Promoter Methylation in Glioblastoma Stem Cells: Stability During Differentiation and Comparison With Surgically-resected Tumors
Show more Experimental Studies

Similar Articles

Keywords

  • miR-21 inhibitor
  • HNSCC
  • lipid nanoparticles
  • xenograft
  • TUNEL
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire